Paul Offit, MD, chief of Children’s Hospital’s Division of Infectious Diseases, has long been a magnet for controversy. A co-creator of the rotavirus vaccine Rotateq, Dr. Offit’s willingness to speak his mind, question popular (and at times ill-informed) wisdom, and to defend science against its detractors has earned him many vocal critics over the years.
A recent study of an “antimicrobial stewardship” program by Children’s Hospital researchers found that offering pediatricians education, and auditing their prescription patterns, can encourage them to choose more appropriate antibiotics for children with common respiratory infections.
For many teens, summer is just getting underway. But increased time spent outdoors also comes with increased safety concerns: Sun exposure, swimming, biking, and hiking can all increase the risk of various adolescent injuries.
As anyone who has been to a doctor knows, a standard part of a doctor’s visit or wellness exam is determining a patient’s BMI. But what exactly does “BMI” mean? And what can it tell clinicians about their patients?
The Children’s Hospital of Philadelphia (CHOP) earned the number one ranking in the 2013-14 U.S. News & World Report Honor Roll of Best Children’s Hospitals announced today.
The Children’s Hospital of Philadephia is proud to announce the birth of its 1,000th fetal surgery patient. Audrey Rose Oberio was born May 28 to Jackie and Gideon Oberio. The Oberios traveled to CHOP from Maryland so Audrey could be treated for myelomeningocele, the most severe form of spina bifida, at Children’s Hospital’s Center for Fetal Diagnosis and Treatment.
A group of prominent vaccine researchers, including The Children’s Hospital of Philadelphia Research Institute’s chief scientific officer, Philip R. Johnson, MD, and the University of Pennsylvania’s Stanley Plotkin, MD, recently called for a “human vaccines project” to accelerate the development of vaccines to prevent “major global killers such as AIDS, tuberculosis, malaria, and other infectious diseases.”
Tara Wenger, MD, PhD, a Pediatric Genetics fellow in the Center for Autism Research, was recently featured in a number of articles about an exciting new study of autism.
Yesterday, CBS Sunday Morning featured a story on the anaplastic lymphoma kinase, or ALK, clinical trial for lymphoma and neuroblastoma and CHOP’s partnership with the Alex's Lemonade Stand Foundation, which supported the basic research.
Wallace studies mitochondria, tiny structures that serve as our cells’ “power plants,” converting food and oxygen into energy. Mitochondria are actually symbiotic bacteria that invaded our cells more than 2 billion years ago.